IX1:ETR
Idexx Laboratories
500,80 €
arrow_upward
+2,29%(+11,20) 1 pv
17.4., 17.35.46 UTC+2 · EUR
search
Kaikki symbolit
1 pv
5 pv
1 kk
6 kk
YTD
1 v
5 v
MAKS
| Symboli | Hinta | Muutos | Muutos (%) |
|---|
Uutiset
Eri verkkolähteistä
MarketBeat
·
2 päivää sitten
Arizona State Retirement System Decreases Stock Holdings in IDEXX Laboratories, Inc. $IDXX
TIKR.com
·
3 päivää sitten
Why IDEXX Laboratories Stock Is Undervalued at $561 in 2026
Profiili
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
Tekoälyn luoma sisältö voi sisältää virheitä. Lue lisää